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Exit from the endoplasmic reticulum (ER) is an important checkpoint for proper assembly 
of multimeric plasma membrane receptors. The six subunits of the T cell receptor (TCR; TCR
 

 
, 
TCR
 

 
, CD3
 

 
, CD3
 

 
, CD3
 

 
, and CD3
 

 
) are each endowed with ER retention/retrieval signals, 
and regulation of its targeting to the plasma membrane is therefore especially intriguing. 
We have studied the importance of the distinct ER retention signals at different stages of 
TCR intracellular assembly. To this end, we have characterized first the presence of ER 
retention signals in CD3
 

 
. Despite the presence of multiple ER retention signals in CD3
 

 
, 
 
 
 
dimers reach the cell surface when the single CD3
 
 
 
ER retention signal is deleted. 
Furthermore, inclusion of this CD3
 
 
 
mutant promoted plasma membrane expression of 
incomplete 
 
 
 
and 
 
 
 
complexes without CD3
 

 
. It therefore appears that the CD3
 
 
 
ER retention signal is dominant and that it is only overridden upon the incorporation of 
CD3
 

 
. We propose that the stepwise assembly of the TCR complex guarantees that all 
assembly intermediates have at least one functional ER retention signal and that only 
a full signaling-competent TCR complex is expressed on the cell surface.
 
Multimeric plasma membrane protein com-
plexes typically assemble early in the secretory
pathway, in parallel with the synthesis and
folding of individual subunits in the ER. Exit
from the ER is an important checkpoint for
many such complexes, as only fully assembled
complexes are allowed to pass this control
step (1). ER retention/retrieval signals (herein
referred to as ER retention signals) are present
in some receptor subunits, and the assembly of
complexes is thought to mask the ER retention
signal, permitting targeting to the membrane
of the fully assembled complexes (2). The
TCR is an especially complex model because
it is formed by six different subunits that all
contain ER retention determinants.
In the TCR, the TCR
 
 
 
and TCR
 
 
 
sub-
units (or TCR
 
 
 
and TCR
 
 
 
in 
 
 
 
T cells)
are responsible for the recognition of the
MHC/antigen ligand. These are noncovalently
bound to the signal-transducing subunits
CD3
 

 
, CD3
 

 
, CD3
 

 
, and CD3
 
 
 
(the CD3
 

 
subunit is CD247). During assembly, CD3
 

 
first dimerizes with either CD3
 
 
 
or CD3
 

 
, and
the resulting 
 
 
 
and 
 
 
 
dimers associate with
the TCR
 
 
 
and TCR
 
 
 
subunits (3–5). The re-
sulting 
 
 
 
or 
 
 
 
complexes are either re-
tained in the ER or degraded in lysosomes (6).
Only when CD3
 
 
 
is incorporated into the
complex is the TCR transported to the plasma
membrane (6–8). In this way, expression of
signal-transducing subunits independent of
ligand-binding subunits or vice versa is tightly
controlled. Indeed, in T cell mutants and
knockout mice lacking TCR
 

 
, CD3
 

 
, or
CD3
 

 
, TCR expression is severely impaired
(9–12). In addition, T cell precursors in RAG-
deficient and SCID mice that are unable to
express the TCR gene subunits have a very
low level of CD3 
 
 
 
and 
 
 
 
dimer expression
at the cell surface (13, 14), and their develop-
ment is arrested at the most immature CD4
 

 
CD8
 
 
 
stage.
Removal of the ER retention signal in the
cytoplasmic tail of CD3
 
 
 
permits this subunit to
reach the cell surface by itself (15, 16). This sig-
nal consists of an elongated 
 
 
 
helix followed by
a 
 

 
I
 
 
 
turn and contains three important, closely
spaced residues: tyrosine, leucine, and arginine.
The presence of arginine in the ER retention
signal is characteristic of type II proteins despite
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the fact that CD3
 
 
 
is a type I membrane protein (17–19).
Other ER retention signals in the TCR have not been ana-
lyzed in detail, although TCR
 
 
 
contains an ER retention
signal in its transmembrane region (20) and TCR
 
 
 
in both
its extracellular and transmembrane domains (21). With re-
gard to the other CD3 subunits, CD3
 
 
 
has a conserved argi-
nine residue in position 
 

 
3 from the COOH terminus, and
CD3
 
 
 
has either an arginine or a lysine residue at the same
position. Their removal from Tac
 
 
 
and Tac
 
 
 
chimeras dis-
rupts ER retention (22).
In addition to ER retention signals, binding of incom-
pletely folded subunits and complexes to chaperonins such as
calnexin can also influence ER retention (23). Moreover,
endocytosis signals in several subunits of the TCR complex
offer a further level of regulation (22, 24, 25). The CD3
 

 
subunit contains an important double leucine signal for en-
docytosis that is hidden in the complete TCR complex but
unmasked by PKC-mediated phosphorylation of an up-
stream serine (26). In partial complexes, this double leucine
signal is constitutively exposed and only masked upon inte-
gration of CD3
 
 
 
into the TCR complex (27, 28).
During assembly, all individual ER retention determinants
in TCR subunits must be annulled before the TCR complex
can be transported to the plasma membrane. The ER reten-
tion determinants may become progressively overridden as the
TCR complex assembles or alternatively, all determinants
might become inoperative at once, when all the TCR sub-
units are assembled. To study this process, we have character-
ized the ER retention signals in CD3
 
 
 
and analyzed the pre-
dominance of CD3
 
 
 
and CD3
 
 
 
signals in the 
 
 
 
dimer. All
the determinants in CD3
 
 
 
are overridden when it assembles
with CD3
 

 
. However, the single ER retention signal in CD3
 

 
remains active in the 
 
 
 
dimer and only becomes inoperative
upon completion of the last assembly step, i.e., the incorpora-
tion of CD3
 

 
. These results support a model of sequential in-
activation of ER retention signals during stepwise assembly.
 
RESULTS
The cytoplasmic tail of CD3
 
 
 
contains multiple intracellular 
trafficking signals
 
To identify ER retention signals in the cytoplasmic tail of
CD3
 

 
, a chimeric protein containing the CD3
 
 
 
cytoplasmic
tail appended to the human CD4 extracellular and trans-
membrane domains was generated (chimera 44
 

 
; Fig. 1 A).
The chimera was transfected into COS cells, and cell surface
expression was analyzed by flow cytometry. Expression of
the 44
 
 
 
chimera at the cell surface was 2.5-fold lower than
that of wild-type CD4 (Fig. 1 B). Furthermore, unlike CD4,
the 44
 
 
 
chimera was predominantly located in the ER of
transfected COS cells, with a similar distribution to CD3
 

 
(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20041133/DC1). These results indicated that the cyto-
plasmic tail of CD3
 
 
 
contains an ER retention signal.
To characterize this putative ER retention signal, five de-
letion mutants of the 44
 
 
 
chimera were generated and trans-
fected into COS cells (Fig. 1 A). Deletion of the three
COOH-terminal amino acids (44
 
	
 
1) promoted a moderate
increase in surface expression of the chimera (Fig. 1 B). This
effect was slightly accentuated when five or nine additional
amino acids were deleted from the COOH-terminal end
(44
 
	
 
2 and 44
 
	
 
3). In contrast, deletion of seven more
amino acids (44
 
	
 
4) provoked an important reduction in
44
 
 
 
expression (Fig. 1 B), suggesting that a signal that facili-
tates transport to the plasma membrane might reside between
amino acids 142 and 148. Finally, deletion of most of the cy-
toplasmic tail, including the double leucine endocytotic sig-
nal, enhanced surface expression to above the levels of wild-
type CD4. This could be due to the 44
 
	
 
5 mutant lacking
not only the double leucine endocytotic signal of CD3
 

 
, but
also that of the cytoplasmic tail of CD4 (29). The increase in
surface expression of the mutant chimeras was coincident
with a redistribution of the chimera to the Golgi apparatus,
plasma membrane, and vesicular structures (Fig. S1).
The fact that some 44
 
 
 
chimera was detected at the
plasma membrane might be due to excessive protein expres-
sion in transfected COS cells, thereby overriding the ER re-
tention machinery. Hence, we studied the surface expression
of the 44
 
 
 
chimera in stable transfectants of the human NK
cell line YT. Several cell clones with each construct were
studied to exclude clonal effects. Only the mutant 44
 
	
 
5
was expressed at the cell surface at a level that matched that
of wild-type CD4 (Fig. 1 C). There was only a slight in-
crease in surface expression of chimeras 44
 
	
 
1 through
44
 
	
 
3 and a marginal reduction of 44
 
	
 
4.
We determined how the rate of exit from the ER was af-
fected in these 44
 
 
 
mutants. Human CD4 has two 
 
N
 
-glyco-
sylation sites, one of which is converted to the complex type
in the mature protein (30). Hence, we assessed the acquisi-
tion of partial endo-H resistance of the 44
 
 
 
mutants after
metabolic labeling of the COS cells. Export from the ER of
the 44
 
	
 
1 and 44
 
	
 
2 chimeras was accelerated twofold.
These mutants required 50 min to acquire 50% endo-H re-
sistance (t
 
1/2 
 

 
 
50) compared with the 95 min for wild-type
44
 
 
 
(Fig. 1, D and E). Deletion of further amino acids re-
duced the exit rate to t
 
1/2 
 

 
 
115 min for 44
 
	
 
3, whereas the
ER export of 44
 
	
 
4 and 44
 
	
 
5 was dramatically reduced
(t
 
1/2 
 
 
 
120 min). Thus, it seemed clear that signals other
than those for ER retention also regulate the level of 44
 

 
chimera surface expression.
The cytoplasmic tail of CD3
 
 
 
contains a di-leucine en-
docytotic motif (Fig. 1 A; reference 25) and a putative DxE
ER export signal (31). The combination of ER retention,
export, and endocytosis is ultimately responsible for the sur-
face expression of the 44
 
 
 
mutants. Deletion of the ER re-
tention signal in the COOH-terminal end of the chimera
might explain the accelerated rate of ER export for 44
 
	
 
1
and 44
 
	
 
2, whereas removal of the putative DxE ER ex-
port signal would explain the decrease in ER export of
44
 
	
 
4 and 44
 
	5. The diminished ER exit of 44	3 com-
pared with 44	2 might be due to a positional effect on the
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DxE signal. Nevertheless, it seems that the di-leucine en-
docytotic signal is mainly responsible for regulating the sur-
face levels of the 44 chimera. This could explain why only
44	5 is highly expressed at the surface despite the reduced
rate of ER export (Fig. 1, B, C, and E).
CD3 contains ER retention determinants in its 
extracellular, transmembrane, and cytoplasmic domains
To further characterize this ER retention signal and to de-
termine the impact this signal has on 44 chimera surface
expression, point mutations of the last three amino acids
were introduced. To avoid interference from the di-leucine
internalization signal, leucine 131 was replaced by alanine.
Expression of the double mutants at the cell surface was ana-
lyzed in transfected COS cells and in stable YT transfectants.
In both cell types, mutation of the di-leucine motif alone
(44L131A mutant) caused a two- (COS cells) to sixfold (YT
cells) increase in surface expression of the 44 chimera
(Fig. 2 A). Replacement of arginine 158 with alanine
(44L131A/R158A mutant) resulted in an additional two- (COS
Figure 1. Deletion mapping of ER retention sequences in the 
cytoplasmic tail of CD3. (A) Schematic representation of the 44 chi-
mera with the extracellular and transmembrane domains of CD4 and the 
cytoplasmic tail of CD3. The full amino acid sequence of the CD3 tail is 
shown. The numbers refer to the position of cytoplasmic amino acids in 
CD3. The di-leucine endocytosis motif is underlined, the two tyrosines of 
the ITAM are circled, and the putative DxE ER export motif is in bold. The 
last amino acid in each of the five COOH-terminal deletions is indicated. 
(B) Surface expression of the 44 deletion mutants. COS cells were trans-
fected with the indicated constructs and analyzed by flow cytometry after 
staining with anti-CD4 antibody. Normalized surface expression was 
calculated after multiplying the percentage (nonpermeabilized/permeabi-
lized samples) by the MFI of CD4 cells. (C) Surface expression of the 44 
deletion mutants in the YT human NK cell line. 20–30 stable clones for 
each of the constructs was analyzed after staining with anti-CD4 and flow 
cytometry. Surface expression in the four clones with the highest anti-
CD4 staining per construct is represented as MFI. (D) Acquisition of partial 
endo-H resistance of 44 deletion mutants. COS cells were transfected 
with the indicated constructs, pulse-labeled with 35S-methionine, and 
chased for the indicated times. Immunoprecipitation was performed with 
an anti-CD4 antibody. Each immunoprecipitate was split, and one half was 
digested with Endo-H. (E) The rate of ER export for 44 chimeras was 
calculated from the rate of conversion to partial endo-H resistance. The 
two bands appearing upon digestion with endo-H (D) represent a fully 
endo-H–sensitive (lower band) and a partly endo-H–resistant (upper band) 
form of 44. Both protein bands were quantified by densitometry and the 
ratio of the upper band to the sum of both bands was taken as the endo-H 
resistance conversion rate and as the rate of ER export.
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cells) to fourfold (YT cells) increase in surface expression. In
contrast, mutation of the other two COOH-terminal amino
acids (44L131A/N160A and 44L131A/R159A mutants) did not
have a major impact on cell surface expression. The effect of
arginine 158 mutation was also reflected in the cellular redis-
tribution of this 44 mutant (Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20041133/DC1). Thus,
of the three amino acid residues deleted in mutant 44	1,
only arginine 158 seems to be important for ER retention
of 44.
Once an ER retention signal had been identified in the
cytoplasmic tail of CD3, we evaluated the role of this signal
in the context of the whole CD3 molecule. Surprisingly,
mutation of arginine 158 to alanine in CD3 did not pre-
vent ER retention, because the mutant was exclusively lo-
cated in the ER when examined by confocal microscopy
(Fig. 2 B). Nor was CD3 redistributed to the plasma mem-
brane when an additional mutation in the di-leucine motif
was introduced (Fig. 2 B, L131A/R158A). These results sug-
gested that CD3 contains other ER retention determinants
in addition to the COOH-terminal signal. Furthermore, a
truncated CD3 with only the first two cytoplasmic amino
acids of CD3 was still retained in the ER in COS cells, sug-
gesting that ER retention determinants were present in the
extracellular and/or transmembrane domains (Fig. 2 B, tr).
Indeed, two new domain shuffle chimeras were both re-
tained in the ER: 44, with the extracellular domain of
CD3, and 44, with the CD3 transmembrane domain
(Fig. 2, C and D).
Expression of the CD4/CD3 chimeras and of the
CD3 point mutants was also evaluated by flow cytometry.
Surface expression of the single di-leucine motif mutant of
CD3 (L131A) was slightly higher than the wild-type CD3
but lower than the mutant in the cytoplasmic ER retention
signal (Fig. 2 E, R158A). The double mutation of the cyto-
plasmic ER and endocytotic signals (L131A/R158A) acted syn-
ergistically to increase the surface expression of CD3. Nev-
ertheless, all CD4-CD3 chimeras and CD3 mutants were
expressed at lower levels than CD4 (Fig. 2 E), further indi-
cating that ER retention determinants reside not only in the
cytoplasmic tail of CD3, but also in the transmembrane and
extracellular domains. These extracellular and transmem-
brane retention determinants in CD3 could represent dis-
tinct sequence motifs or an unfolded state of the protein. In
any case, it appears that in contrast to CD3, which contains
a single ER retention signal (15), retention of free CD3 is
regulated by multiple signals. It therefore seems that the ex-
pression of CD3 on the cell surface is tightly regulated.
Dimerization with CD3 abolishes all ER retention 
determinants in CD3
One of the earliest steps in TCR assembly is the dimeriza-
tion of CD3 with either CD3 or CD3 (3, 4, 6). The re-
sulting  and  dimers are retained in the ER unless they
assemble with TCR, TCR, and CD3. Because both
Figure 2. CD3 contains ER retention determinants in its extra-
cellular, transmembrane, and cytoplasmic domains. (A) Arginine to 
alanine substitution at position 158 increases the surface expression of 
the 44 chimera. Single or double point mutants of 44 were either 
transiently transfected in COS cells or stably transfected in YT cells, and 
cell surface expression of the chimera was analyzed by flow cytometry. 
(B) Intracellular distribution of mutants in the cytoplasmic tail of CD3. 
COS cells were transfected with constructs featuring single point muta-
tions in either the double leucine endocytosis motif or the cytoplasmic ER 
retention signal, or with a double mutant (L131A/R158A), and their expres-
sion pattern was analyzed by confocal microscopy after staining with 
anti-HA mAb. A mutant of CD3 lacking the cytoplasmic domain (tr) was 
analyzed in the same way. (C) Domain-shuffling CD4-CD3 chimeras. The 
CD3 domains are dotted. (D) Intracellular distribution of domain-
shuffling chimeras in COS cells. COS cells were transfected with the 
indicated chimeras and analyzed by confocal microscopy after staining 
with anti-CD4 (for CD4 and 44) or anti-HA (for HA-tagged 44 and 44). 
(E) Surface expression of domain-shuffled chimeras and CD3 point 
mutants. COS cells transfected as in B and D were analyzed by flow 
cytometry for surface expression after staining with anti-HA or anti-CD4 
antibodies.
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CD3 and CD3 contain ER retention signals, we exam-
ined the relative contribution of each signal to dimer reten-
tion. COS cells were cotransfected with the CD3 mutants
and CD4 chimeras (refer to Fig. 2) and either wild-type
CD3 or a deletion mutant of CD3 lacking its single ER
retention signal (mut; reference 15). The 44 chimera was
excluded from this study because it lacks the extracellular
domain of CD3 necessary for assembly with CD3 (32).
Cellular distribution of the dimers was distinguished from
that of the single chains by immunostaining with a CD3
dimer-specific antibody, UCHT1 (33). When associated
with wild-type CD3, all CD3 chimeras and mutants were
located in the ER, independent of the presence of CD3
ER retention and endocytotic signals (Fig. 3 A). However,
transfection of mut resulted in export of the  dimers
from the ER and targeting to the plasma membrane (Fig. 3,
A and B). The same effect was seen when wild-type CD3
and mut were expressed in COS cells (not depicted).
In the absence of the CD3 ER retention signal, the 
dimer was transported to the cell surface regardless of the
CD3 cytoplasmic ER retention signal (compare R158A with
 in Fig. 3 B). However, mutation of the CD3 di-leucine
endocytosis signal increased cell surface expression of the 
dimer fourfold (Fig. 3 B, L131A). Expression did not increase
further when the cytoplasmic ER retention signal of CD3
was mutated as well as the endocytotic signal (L131A/R158A),
nor in the absence of the whole cytoplasmic tail (tr), nor in
the absence of both the transmembrane and cytoplasmic do-
mains (44).
These results suggest that the only functional ER reten-
tion signal in the  dimer is that in CD3, and all ER re-
tention determinants in CD3 are abrogated upon dimeriza-
tion with CD3. Therefore, the ER retention determinants
in CD3 do not seem to play a major role in regulating 
expression at the cell surface. However, CD3 does contrib-
ute to this task by mediating the endocytosis of the  dimer
via its di-leucine signal.
The single ER retention signal of CD3 is only overridden 
during the last assembly step
Once  (or ) dimers are assembled in the ER, they asso-
ciate with the TCR and TCR chains to form  and
Figure 3. Deletion of the single ER retention signal in CD3 is 
sufficient for surface expression of the  dimer. (A) Intracellular 
distribution of the  dimer comprising combinations of wild-type and 
mutant CD3 and CD3. COS cells were transfected with combinations of 
either wild-type CD3 or the ER retention mutant mut and the indicated 
CD3 mutants. Cells were double stained with anti-HA antibody (green) to 
identify both free and CD3-associated CD3 and with UCHT1 (red) to 
identify the  dimer. Cells transfected with wild-type CD3 or mut were 
stained with anti-CD3 antibody SP34. (B) Surface expression of the  
dimer. The transfected cells described in A were also analyzed for surface 
expression of the  dimer by flow cytometry after staining with UCHT1.
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 complexes. These incomplete TCR–CD3 complexes
remain in the ER or are degraded in lysosomes. The TCR
complex can only reach the plasma membrane when the 
subunit is incorporated (6–8, 34). Indeed, reconstruction of
the TCR complex in HeLa cells showed that transfection of
the  subunit was sufficient to drive transport of  and
 complexes to the cell surface (35). Bearing this in
mind, we studied whether the CD3 ER retention mutant
promoted surface expression of the  complex or
whether assembly of  was still required. COS cells were
transfected with plasmids encoding these subunits, but the
L131A mutant was used to avoid internalization of the 
complex. When transfected with the CD3 ER retention
mutant, both the CD3 dimer and TCR were trans-
ported to the plasma membrane, even in the absence of 
(Fig. 4 A). Two-color flow cytometry with anti-TCR and
anti-CD3 antibodies was used to quantify the  com-
plex on the cell surface. This showed that the  complex
is expressed at a high level independent of  (Fig. 4 B). In
contrast, when wild-type CD3 was transfected, TCR and
the CD3 dimer were predominantly found in the ER and
were consequently practically undetectable at the cell surface
(Fig. 4, A and B). Similar results were obtained when wild-
type CD3 instead of the di-leucine mutant was used, al-
though surface expression of the  complex reached
lower levels (Fig. S3, available at http://www.jem.org/cgi/
Figure 4. Deletion of the single ER retention signal in CD3 is suf-
ficient for surface expression of the incomplete  complex. (A) 
Intracellular distribution of the TCR–CD3 chains in cells transfected with 
wild-type CD3 or the mut ER retention mutant. COS cells were trans-
fected with the constructs indicated on the right, permeabilized, and triple 
stained with the anti- antibody UCHT1 (green), anti-TCR antibody 
Jovi.1 (red), and anti-CD3 antibody 448 (blue) before analyzing by confo-
cal microscopy. A higher magnification of the area shown in the insets 
illustrates the presence of the TCR complexes in the ER or the plasma 
membrane. (B) Surface expression of the incomplete  complex. 
Transfected cells described in A were double stained with mAbs specific 
for TCR and the  dimer in nonpermeabilized and detergent-
permeabilized cells. The percentage of double labeled cells is indicated in 
each histogram. The percentage of surface expression was calculated from 
the surface to intracellular expression ratio.
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content/full/jem.20041133/DC1), probably because the
 complex was being endocytosed. These results show
that mutation of the CD3 ER retention signal is sufficient
for transport and expression of the incomplete  com-
plex to the cell surface. Interestingly, the presence of  did
not induce a major increase in the surface expression of
complexes containing wild-type CD3, possibly due to the
inefficient assembly of CD3 into the  complex.
To confirm that the CD3 ER retention signal is also
dominant in the complexes lacking CD3 ( and )
in T cells, we transfected human wild-type CD3 and hu-
man mut into the CD3-deficient mutant MA5.8 of the
murine hybridoma 2B4 (36). Human CD3 can assemble
with murine TCR chains, and its cell surface expression can
be followed by flow cytometry with anti–human CD3 anti-
bodies (37). Stable transfectants were analyzed by two-color
flow cytometry using an anti–human CD3 dimer antibody
and an anti-murine TCR antibody. Transfection of human
wild-type CD3 in -sufficient 2B4 cells led to its incorpo-
ration into a sizeable population that was not observed in
-deficient MA5.8 cells (Fig. 5 A). However, transfection of
mut led to its expression in both the -expressing and -defi-
cient cell lines, although it was expressed less in the absence
of CD3. The level of human CD3 expression on the cell
surface was also examined with an anti-CD3 antibody in
flow cytometry and compared with its intracellular expres-
sion in detergent-permeabilized cells. Wild-type CD3
clearly failed to reach the cell surface in -deficient cells de-
spite the intracellular accumulation of the protein (Fig. 5 A).
Finally, all the transfectants were surface biotinylated and the
human CD3-containing complexes were recovered with
an anti–human CD3 antibody. The immunoprecipitates
were resolved by two-dimensional SDS-PAGE under non-
reducing/reducing conditions and showed that mut was in-
deed expressed at the cell surface and was associated with the
murine TCR, TCR, CD3, CD3, and CD3 chains
(Fig. 5 B). Wild-type human CD3 was again not detected
in -deficient cells.
Expression of TCR complexes containing the human
CD3 ER retention mutant was clearly lower in -deficient
than in -expressing cells (Fig. 5). This might reflect the fact
that incorporation of CD3 is required to hide the di-leucine
endocytosis signal in CD3 (27, 28). These results show that
the TCR complex can be exported to the plasma membrane
in the absence of CD3 when the CD3 ER retention signal
is eliminated. Furthermore, the results confirm that the
CD3 ER retention signal prevents cell surface expression of
the incomplete  and  complexes and suggest that
Figure 5. Deletion of the ER retention signal in CD3 is sufficient 
to allow surface expression of the TCR complex in -deficient T 
cells. (A) Surface expression of TCR complexes in -expressing and
-deficient T cells. The parental murine T cell hybridoma 2B4 and its
-deficient MA5.8 mutant were stably transfected with either wild-type 
human CD3 or with human mut. Cells were double stained with the 
anti-murine TCR antibody H57-597 and the anti–human CD3 antibody 
Leu4 and analyzed by two-color flow cytometry (top). Representative 
clones for each condition are shown. The result of single staining with 
anti–human CD3 antibody SK7 of intact or detergent-permeabilized cells 
is shown in the middle and bottom rows. (B) The ER retention mutant of 
CD3 is expressed at the cell surface within a TCR complex. The human 
CD3-transfected clones were surface biotinylated and immunoprecipi-
tated with Leu4 from Brij96 detergent lysates. The immunoprecipitates 
were resolved by two-dimensional nonreducing/reducing SDS-PAGE and 
immunoblotted with streptavidin-peroxidase. The positions of human and 
murine TCR and CD3 chains are indicated.
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this signal becomes inoperative only upon completion of the
last assembly step with the incorporation of CD3.
Masking of the CD3 ER retention signal upon CD3 
assembly is position dependent
A prediction of the stepwise model of ER retention signal
annulment is that silencing of a given ER retention signal
must be position specific; e.g., if CD3 assembly overrides
the ER retention signal in CD3, this must occur in the
context of the specific topological position of CD3 in the
TCR complex. To evaluate this hypothesis, we constructed
two new CD3 chimeras. In one of the chimeras, the cyto-
plasmic tail of CD3 was substituted by the tail of CD3
(Fig. 6 A,  chimera). The other chimera was generated
by appending the ER retention signal of CD3 at the
COOH-terminal end of CD3 (Fig. 6 A, ret). Next, we
examined whether assembly of the CD3 chimeras with the
ER retention mutant of CD3 resulted in expression of the
 dimer at the cell surface. As previously demonstrated
(Fig. 3), assembly of wild-type CD3 with mut but not
with wild-type CD3 allowed transport of the  dimer to
the cell surface (Fig. 6 B). In contrast, assembly of the CD3
chimeras  and ret with mut prevented export of the
 dimer to the plasma membrane (Fig. 6 B) and retained
the dimer in the ER (Fig. S4, available at http://www.jem.
org/cgi/content/full/jem.20041133/DC1). These results there-
fore show that abrogation of the ER retention signals during
assembly of the  dimer is dependent on both the sequence
of the cytoplasmic tail and the position of the ER retention
signals within the dimer.
To extend these results to the full TCR complex, a
CD3 mutant of Jurkat was transfected with wild-type
CD3 or with the  or ret chimeras, and stable clones
were selected. Transfection of wild-type CD3 but not the
 or ret chimeras reconstituted the surface expression of
the TCR complex at high levels (Fig. 6 C). These results
show that if the CD3 ER retention signal is misplaced (ei-
ther at the position of the CD3 tail or at the tip of CD3),
CD3 assembly can no longer silence it.
DISCUSSION
In this study, we have tried to better understand the mecha-
nisms that regulate expression of TCR–CD3 complexes at
the cell surface and prevent nonassembled subunits and in-
complete complexes from reaching or remaining in the
plasma membrane. We found that removal of the CD3 ER
retention signal is sufficient to permit expression of  and
 dimers at the surface of transfected COS cells. Indeed,
even though CD3 contains multiple ER retention signals,
these signals all become inoperative upon assembly with
Figure 6. Translocation of the CD3 ER retention signal to CD3 
prevents  dimer and TCR expression. (A) Scheme of CD3 chimeras 
where the CD3 domains are dotted. The presence of CD3-derived 
sequences (the whole cytoplasmic tail in  or the last 15 amino acids in 
ret) is indicated with black boxes. The three constructs were HA tagged at 
their NH2 terminus. (B) Abrogation of the cytoplasmic ER retention signal 
in CD3 is position dependent. COS cells were transfected with combina-
tions of either wild-type CD3 or the ER retention mutant mut and the 
indicated CD3 chimeras. Surface expression of the  dimer was analyzed 
by two-color flow cytometry with anti-HA and anti-CD3 dimer (Leu4) 
antibodies in nonpermeabilized cells. Intracellular expression of the  
dimer was assessed by two-color flow cytometry of detergent-permeabilized 
cells (not depicted). The percentage of  dimer-positive cells is indicated 
in the corresponding quadrants. (C) Abrogation of the CD3 ER retention 
signal upon CD3 assembly is position dependent. Jurkat CD3 R3.25 
cells were stably transfected with the indicated CD3 constructs, and 
geneticin-resistant clones were analyzed for TCR expression by double 
color flow cytometry with anti-HA and anti-CD3 (Leu 4) antibodies. The 
seven clones with the highest TCR expression for each construct are repre-
sented at the bottom. Two-color flow cytometry histograms for the clones 
with highest TCR expression are shown at the top. The total number of 
clones analyzed was 42 for the wild-type CD3 construct, 14 for the ret 
construct, and 48 for the  construct. NT, nontransfected.
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CD3. Furthermore, our results show that the absence of
the CD3 ER retention signal is sufficient to allow the ex-
pression of incomplete TCR complexes in the plasma mem-
brane, even when lacking CD3.
Dual regulation through ER retention signals and pro-
teasome-dependent degradation from the ER prevents TCR
subunits from progressing through the secretory pathway
(38, 39). ER retention signals have been described in CD3,
TCR, TCR, CD3, and CD3 (15, 20–22, and this
study), and it could be considered that all ER retention sig-
nals are abrogated simultaneously when the full TCR com-
plex is assembled. However, our findings indicate that there
is a hierarchy among retention signals such that they become
overridden progressively as the TCR complex assembles.
Hence, we propose a model for the export of the TCR
complex (Fig. 7) in which the ER retention signals of
CD3, CD3, TCR, and TCR become progressively in-
operative as they assemble with CD3. The ER retention
signal in CD3 remains dominant in these complexes.
When is the ER retention signal in CD3 overridden?
We postulate that this takes place after association of ,
which has been long known to be the last step in assembly
(6–8). This idea was not confirmed by our reconstitution
studies in COS cells, because efficient cell surface expression
of the  complex with wild-type CD3 was not ob-
served. This might indicate that CD3 is mandatory for sur-
face expression. However, our transfection experiments (not
depicted) and the results of Kappes and Tonegawa (35) sug-
gest that this is not the case. Moreover, transfection of all
TCR subunits in non–T cells is sufficient to detect the full
TCR complex at the cell surface (35, 40). This discrepancy
might be explained by the greater sensitivity of radio iodina-
tion (40) compared with the flow cytometry used here, or
by the fact that the transfected population underwent selec-
tion for high TCR expression (35). However, the poor effi-
ciency of ER export and the weak surface expression of the
wild-type CD3-containing  complex might be bet-
ter explained by the inefficient assembly of CD3 into the
complex. Nevertheless, the results in COS cells and the
model (Fig. 7) have been validated in -expressing and
-deficient murine T cells transfected with human CD3 (Fig. 5).
Human wild-type CD3 is targeted to the plasma membrane
within the TCR complex only after assembly of CD3,
whereas the human CD3 ER retention mutant can reach
the membrane with and without CD3. Studies in CD3-
deficient mice and cell lines show that TCR–CD3 surface
Figure 7. Model of sequential inactivation of TCR retention signals. 
Surface expression of free CD3 is prevented by a single ER retention 
signal (triangle), whereas expression of free CD3 is prevented by several 
ER retention signals (triangles) and a di-leucine endocytosis signal (circle). 
CD3 may contain at least one cytoplasmic ER retention signal similar to 
those of CD3 and CD3 (triangle) and a di-leucine endocytosis signal 
(circle). Upon assembly of  and  dimers, the ER retention determi-
nants of CD3 and CD3 are overridden, but surface expression of the  
and  dimers is prevented by the CD3 ER retention signal that remains 
functional. The endocytosis signals in CD3 (and probably CD3) remain 
active in the  and  dimers and are responsible for the internalization 
and removal of the small amounts of dimer that somehow reach the cell 
membrane on their own. TCR and TCR contain additional ER retention 
determinants, but these do not seem to be operative in the  (and 
probably ) complex. Only after assembly of CD3 does the CD3 ER 
retention signal become nonfunctional, thus allowing the full TCR–CD3 
complex to reach the plasma membrane. The stability of the full complex 
on the cell surface is also increased because the CD3 and CD3 endocy-
totic signals are inactive. Removing both the CD3 ER retention signal and 
the CD3 endocytotic signal artificially increases surface expression of 
free  dimers and incomplete  complexes.
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expression is extremely low in the absence of this subunit
(34, 41). Accordingly, our results show that the CD3 ER
retention signal remains functional in the incomplete 
complex, preventing cell surface expression. These results
also indicate that the orderly inactivation of intracellular re-
tention signals serves to not only prevent surface expression
of the CD3 dimer (or TCR dimer), but also that of TCR–
CD3 complexes lacking CD3.
What then is the mechanism that overrides CD3’s ER
retention signal upon assembly of ? It has been proposed
that the cytoplasmic tail of CD3 hides the otherwise ex-
posed di-leucine endocytosis motif in CD3 by steric hin-
drance (28). Indeed, in -deficient cells it has recently been
demonstrated that the TCR is more rapidly internalized and
that expression of CD3, or a CD3 chimera with its cyto-
plasmic tail partially replaced by a foreign sequence, restores
normal TCR internalization (27). Steric masking of the di-
lysine ER retention motif in the  chain of the heterodimeric
high affinity receptor for immunoglobulin E (FcRI) upon
assembly with the  chain has been proposed to regulate
plasma membrane targeting (2). Similarly, steric hindrance
by the cytoplasmic tail of CD3 could be responsible for an-
nulling the CD3 ER retention signal, although other
mechanisms involving CD3-dependent rearrangements of
the TCR complex cannot be excluded. Interestingly, the 
chain of FcRI and CD3 are structural and functionally re-
lated, and indeed, the FcRI  chain can take over the role
of CD3 in TCR assembly in / mice (42–44). These re-
sults suggest a common mechanism underlying ER retention
of immune receptor complexes by components of the CD3
family. In any case, masking of the CD3 ER retention sig-
nal by CD3 assembly is position dependent. Thus, either
replacement of the cytoplasmic tail of CD3 by CD3 or
apposition of an extra CD3 ER retention signal to the
COOH-terminal end of CD3 prevents surface expression
of the full TCR complex (Fig. 6).
We have shown that the di-leucine endocytosis signal of
CD3, together with the ER retention signal in CD3, is
also important to reduce the expression of the  dimer on
the cell surface. Thus, high level expression of the  (and by
extension ) dimer on the cell surface is prevented by im-
pairing its export from the ER–Golgi and by stimulating the
rapid endocytosis of dimers from the cell surface. This regula-
tion of CD3 dimer and free CD3 subunit expression is re-
quired to prevent ligand-independent triggering of signaling
cascades. It has been shown that small amounts of  and 
dimers expressed on the surface of immature thymocytes, also
known as clonotypic-independent complexes, can promote
thymic differentiation and proliferation upon cross-linking
with anti-CD3 antibodies (45). One might ask what would
be the consequence of augmenting the expression of CD3
dimers at the cell surface on thymic maturation. Studies in
which a TCR transgene that lacks the variable region (46),
or even all extracellular domains (47), was expressed in MHC
class I– and II–deficient mice indicate that the pre-TCR
function is independent of ligand recognition. The pre-TCR
could therefore serve merely as a platform to express suffi-
ciently high levels of the CD3 dimers at the cell surface to
initiate ligand-independent signaling. Assembly of the CD3
dimers with TCR, pT, and CD3 must override the
CD3 ER retention signal as well as those in TCR (21) and
pT (48). In this regard, it should be noted that the addition
of an extra ER retention signal to TCR abolishes pre-TCR
function (49). These results suggest that the pre-TCR must
be expressed on the cell surface to carry out its signaling role.
Furthermore, unlike the natural ER retention signals present
in the TCR and CD3 subunits, the artificial signal introduced
in TCR does not appear to be annulled during assembly.
We have made an initial attempt to characterize the sig-
nals that regulate the intracellular retention of the CD3
chain. In accordance with previous observations (22), we
found that the cytoplasmic tail of CD3 contains an ER re-
tention signal at the COOH terminus. Although this se-
quence is reminiscent of the double arginine ER retention
signal in type II membrane proteins (18, 19), we have dis-
covered that only one of the two arginines in CD3 is im-
portant for ER retention. Thus, the cytoplasmic CD3 ER
retention signal better resembles that of CD3, which con-
tains only one important basic residue (arginine 3; refer-
ences 15 and 16). In addition to the ER retention signal, the
cytoplasmic tail of CD3 contains a putative ER export se-
quence of the DxE type (31) and a di-leucine endocytosis
signal (22, 50). However, CD3 also contains ER retention
determinants in its extracellular and transmembrane domains
that have yet to be characterized. These extracellular and
transmembrane retention determinants in CD3 could rep-
resent distinct sequence motifs or an unfolded state of the
protein. In any case, it appears that in contrast to CD3, the
retention of free CD3 is regulated by multiple signals.
In conclusion, the results presented here suggest that the
TCR–CD3 complex is endowed with a complicated system of
intracellular retention signals that become overridden in a step-
wise fashion as assembly proceeds. Assembly is regulated in
such a way that all intermediates have at least one functional re-
tention signal. This system guarantees that only a full signaling-
competent TCR–CD3 complex is expressed at the cell surface.
MATERIALS AND METHODS
Cells. COS-7 cells were obtained from American Type Culture Collection
(ATCC) and grown in DMEM plus 5% FBS (Sigma-Aldrich). The human
NK cell line YT was provided by M. López-Botet (Universidad Pompeu-
Fabra, Barcelona, Spain), the murine 2B4 T cell hybridoma was from the
ATCC, the CD3-deficient mutant MA5.8 of 2B4 was provided by J. Ash-
well (National Institutes of Health, Bethesda, MD), and the CD3-deficient
mutant R3.25 of Jurkat was provided by B. Rubin (CNRS, Toulouse,
France). All cells were grown in RPMI medium plus 5% FBS.
Constructs. All constructs were generated by PCR using human cDNAs
as templates. PCR products were cloned into the pSR or pSR-HA (un-
published data) vectors. The 44 chimera is composed of the extracellular
and the transmembrane domains of CD4 (finishing in position V395 of the
mature polypeptide) fused to the complete intracellular domain of CD3
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(from position A115 of the mature polypeptide). 44	1 to 44	5 constructs
have a stop codon at positions 157, 152, 148, 141, and 121, respectively, of
the mature human CD3 protein. Truncated CD3 (tr) contains only the
first two amino acids of the cytoplasmic tail. Wild-type human CD3 and
the CD3 mutant lacking the last five COOH-terminal amino acids (mut)
have been described (15, 51). Point mutants were generated by introducing
the mutation encoding for alanine in the positions 131, 158, 159, and 160
of the mature human CD3 protein using 44 (44L131A, 44L131A/N160A,
44L131A/R159A, and 44L131A/R158A) or CD3 (L131A, R158A, and L131A/R158A)
as template. The 44, 44, and  constructs were created as isolated frag-
ments by PCR, cloned into the intermediate vector pGEM-7Zf(), and
the chimeric cDNAs were subcloned into the pSR-HA vector. The ret
construct was created by PCR using a 3 primer encoding for the last
COOH-terminal 15 amino acids of human CD3 (KGQRDLYSGLNQRRI)
appended to the last amino acid of CD3, and the PCR product was cloned
into the pSR-HA vector.
Antibodies. The mAb anti–human SP34 that recognizes the CD3 extra-
cellular domain, the mAb anti–human CD3 UCHT1, the mAb anti–human
CD4 HP2/6, and the mAb anti–C Jovi.1 were provided by C. Terhorst
(Beth Israel Deaconess Hospital, Boston, MA), P. Beverley (The Edward
Jenner Institute for Vaccine Research, Berkshire, UK), F. Sánchez-Madrid
(Hospital de la Princesa, Madrid, Spain), and M. Owen (CRUK, London,
UK), respectively. The anti-CD3 antiserum 448 has been described (5).
The following mAbs were purchased as indicated: anti-HA epitope 12CA5
(Roche Diagnostics), anti-murine TCR H57-597 and anti–human CD3
Leu4 (BD Biosciences), and anti–human CD3 SK7 (StemCell Technolo-
gies Inc.). All secondary fluorochrome-labeled antibodies were purchased
from BD Biosciences.
Cell transfections. COS cells were transiently transfected as described
previously (32), and stable transfectants of YT, 2B4, MA5.8, and R3.25
cells were generated by electroporation and selection in geneticin.
Flow cytometry. 24 h after transfection, COS cells were detached from
the plate with 0.02% EDTA in PBS and divided into two aliquots for sur-
face and intracellular staining. For intracellular staining, cells were first fixed
with 2% paraformaldehyde in PBS for 20 min at 4C and then permeabi-
lized with 0.1% saponin in PBS at 4C for 1 h. Permeabilized and nonper-
meabilized cells were incubated with 4 g/ml of the appropriate mAb for
30 min at 4C and then with a secondary FITC- or PE-labeled antibody.
For two-color staining, directly labeled antibodies were used. Surface ex-
pression is indicated as a percentage, as mean fluorescence intensity (MFI),
or by multiplying both parameters.
Confocal microscopy. Upon transfection, COS cells were plated on
glass coverslips, fixed in paraformaldehyde at room temperature 24 h later,
and then permeabilized with saponin as described above. The coverslips
were mounted in Mowiol and examined with a confocal microscope (Ra-
diance 2000; BioRad Laboratories).
Cell labeling and immunoprecipitation. 48 h after transfection, COS
cells were labeled with 35S-methionine for 15 min and then chased for dif-
ferent times in standard medium before lysing with 1% NP-40 lysis buffer
(150 mM NaCl, 20 mM Tris-HCl, pH 7.8, 10 mM iodoacetamide, 1 mM
PMSF, 1 g/ml aprotinin, and 1 g/ml leupeptin). Postnuclear lysates
were immunoprecipitated with an anti-CD4 antibody, and the immuno-
precipitates were resuspended in endo-H buffer (50 mM sodium citrate, pH
5.5, 0.1% SDS, 1 mM PMSF, 1 g/ml aprotinin, and 1 g/ml leupeptin)
before digesting half of the sample with endo-H. The samples were resolved
by SDS-PAGE and analyzed by autoradiography.
For surface biotinylation, 50  106 MA5.8 and 2B4 were incubated
with 0.5 mg/ml sulfo-NHS-biotin (Pierce Chemical Co.) in PBS supple-
mented with 0.1 mM CaCl2 and 1 mM MgCl2 for 45 min on ice. After
washing, surface complexes were recovered by incubating the labeled intact
cells with human anti-CD3 antibody Leu4 before lysis. Protein G was
added and immunoprecipitates were subjected to two-dimensional SDS-
PAGE (first dimension under nonreducing and second dimension under re-
ducing conditions), immunotransferred to a nitrocellulose membrane, hy-
bridized with streptavidin horseradish peroxidase (Southern Biotechnology
Associates, Inc.), and developed by ECL (Bio-Rad Laboratories).
Online supplemental material. Fig. S1 shows intracellular distribution
of 44 deletional mutants. Fig. S2 shows intracellular distribution of the 44
point mutants. In Fig. S3, the ER retention signal in CD3 and the di-leu-
cine endocytosis signal in CD3 both regulate surface expression of the in-
complete  complex. Fig. S4 illustrates the intracellular distribution of
 dimers. Figs. S1–S4 are available at http://www.jem.org/cgi/content/
full/jem.20041133/DC1.
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